PoreWise

One finding · Human trial · 2017

Study title

Clinical efficacy of liposome-encapsulated Aloe vera on melasma treatment during pregnancy

Kind of evidence
Human trial 2017 · 180 people · pregnant women with melasma in the second trimester or later (90 per group) · PMID 28139161
Measured outcome
Skin effect
Year
2017
Who was studied
180 pregnant women with melasma in the second trimester or later (90 per group)
Sample size
180
Measured outcome
In a double-blind randomized trial of 180 pregnant women with melasma in their second trimester or later, 5 weeks of liposome-encapsulated Aloe vera leaf gel extract improved MASI scores by 32% versus 10% with the non-liposomal Aloe vera gel control, with a significant between-group difference in mean MASI after treatment.
Certainty
Moderate
Who was measured
Melasma Area and Severity Index (MASI) over 5 weeks in pregnant women.
Study limits
The comparator is an active Aloe vera gel.

Where it comes from

PMID 28139161

Ingredients it was measured on

Skin concerns studied

Other findings on the same ingredient or concern

  1. Skin effect
    Melasma in pregnancy: reduction of its appearance with the use of a broad-spectrum sunscreen

    In a placebo-controlled trial in pregnant women, daily application of a broad-spectrum SPF 10 sunscreen to the face from the second trimester through summer significantly reduced the appearance of melasma compared with placebo among the 30 women with good adherence (14 sunscreen, 16 placebo).

    Human trial · 1987 · 30 people · pregnant women with good adherence (14 sunscreen / 16 placebo), analysed from a larger enrolled cohort · Appearance of melasma during pregnancy with daily facial sunscreen use. · 30 adherent participants were analysed; SPF 10 is far below current broad-spectrum recommendations; published in 1987 in a Spanish-language journal; the effect is on preventing new melasma.

    PMID 3312862